Your browser doesn't support javascript.
loading
Pseudorabies virus inhibits progesterone-induced inactivation of TRPML1 to facilitate viral entry.
Su, Bing-Qian; Yang, Guo-Yu; Wang, Jiang; Ming, Sheng-Li; Chu, Bei-Bei.
Afiliación
  • Su BQ; College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, China.
  • Yang GY; Key Laboratory of Animal Biochemistry and Nutrition, Ministry of Agriculture and Rural Affairs, Zhengzhou, Henan Province, China.
  • Wang J; Key Laboratory of Animal Growth and Development of Henan Province, Henan Agricultural University, Zhengzhou, Henan Province, China.
  • Ming SL; Key Laboratory of Animal Biochemistry and Nutrition, Ministry of Agriculture and Rural Affairs, Zhengzhou, Henan Province, China.
  • Chu BB; Key Laboratory of Animal Growth and Development of Henan Province, Henan Agricultural University, Zhengzhou, Henan Province, China.
PLoS Pathog ; 20(1): e1011956, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38295116
ABSTRACT
Viral infection is a significant risk factor for fertility issues. Here, we demonstrated that infection by neurotropic alphaherpesviruses, such as pseudorabies virus (PRV), could impair female fertility by disrupting the hypothalamus-pituitary-ovary axis (HPOA), reducing progesterone (P4) levels, and consequently lowering pregnancy rates. Our study revealed that PRV exploited the transient receptor potential mucolipin 1 (TRPML1) and its lipid activator, phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), to facilitate viral entry through lysosomal cholesterol and Ca2+. P4 antagonized this process by inducing lysosomal storage disorders and promoting the proteasomal degradation of TRPML1 via murine double minute 2 (MDM2)-mediated polyubiquitination. Overall, the study identifies a novel mechanism by which PRV hijacks the lysosomal pathway to evade P4-mediated antiviral defense and impair female fertility. This mechanism may be common among alphaherpesviruses and could contribute significantly to their impact on female reproductive health, providing new insights for the development of antiviral therapies.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Seudorrabia / Herpesvirus Suido 1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Seudorrabia / Herpesvirus Suido 1 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: PLoS Pathog Año: 2024 Tipo del documento: Article País de afiliación: China